Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the countries listed. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
A
Class 5 – Pharmaceuticals & supplements
Status timeline
- 29 Oct 2021Application filedNew Application Entered
- 3 Aug 2022Assigned to an examining attorneyAssigned To Examiner
- 10 Aug 2022Approved for publicationApproved For Pub - Principal Register
- 13 Sep 2022Published for oppositionPublished For Opposition
- 8 Nov 2022Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 11 May 2023Statement-of-use extension 1 grantedSou Extension 1 Granted
- 18 Oct 2023Statement-of-use extension 2 grantedSou Extension 2 Granted
- 15 Apr 2024Statement-of-use extension 3 grantedSou Extension 3 Granted
- 14 Mar 2025Statement of use filedTeas Statement Of Use Received
- 18 Mar 2025Statement of use acceptedAllowed Principal Register - Sou Accepted
- 8 Apr 2025Registered on the Principal RegisterRegistered-Principal Register
All 39 events
| 2025-04-08 | Registered-Principal Register |
| 2025-04-08 | Notice Of Registration Confirmation Emailed |
| 2025-03-18 | Allowed Principal Register - Sou Accepted |
| 2025-03-18 | Notice Of Acceptance Of Statement Of Use E-Mailed |
| 2025-03-17 | Statement Of Use Processing Complete |
| 2025-03-14 | Teas Statement Of Use Received |
| 2025-03-14 | Use Amendment Filed |
| 2025-01-27 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2025-01-27 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2025-01-27 | Teas Change Of Correspondence Received |
| 2024-10-31 | Sou Teas Extension Received |
| 2024-10-31 | Sou Extension 4 Filed |
| 2024-10-31 | Sou Extension 4 Granted |
| 2024-10-31 | Notice Of Approval Of Extension Request E-Mailed |
| 2024-04-16 | Notice Of Approval Of Extension Request E-Mailed |
| 2024-04-15 | Sou Teas Extension Received |
| 2024-04-15 | Sou Extension 3 Filed |
| 2024-04-15 | Sou Extension 3 Granted |
| 2023-10-20 | Notice Of Approval Of Extension Request E-Mailed |
| 2023-10-18 | Sou Teas Extension Received |
| 2023-10-18 | Sou Extension 2 Filed |
| 2023-10-18 | Sou Extension 2 Granted |
| 2023-05-12 | Corrected Noa Mailed |
| 2023-05-12 | Notice Of Approval Of Extension Request E-Mailed |
| 2023-05-11 | Divisional Processing Complete |
| 2023-05-11 | Sou Extension 1 Granted |
| 2023-05-10 | Case Assigned To Intent To Use Paralegal |
| 2023-04-24 | Sou Teas Extension Received |
| 2023-04-24 | Teas Request To Divide Received |
| 2023-04-24 | Divisional Request Received |
| 2023-04-24 | Sou Extension 1 Filed |
| 2022-11-08 | Noa Mailed - Sou Required From Applicant |
| 2022-09-13 | Published For Opposition |
| 2022-09-13 | Official Gazette Publication Confirmation E-Mailed |
| 2022-08-24 | Notification Of Notice Of Publication E-Mailed |
| 2022-08-10 | Approved For Pub - Principal Register |
| 2022-08-03 | Assigned To Examiner |
| 2021-11-09 | New Application Office Supplied Data Entered |
| 2021-10-29 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of lung cancer
First use anywhere 14 Nov 2024 · First use in commerce 14 Nov 2024
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 8 Apr 2025; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.